Article
Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society - 1 Apr 2011
Iwasenko J M, Scott G M, Naing Z, Glanville A R, Rawlinson W D
Abstract excerpt
Immunocompromised transplant recipients are at high risk for human cytomegalovirus (CMV)-related infection and disease. Antiviral prophylaxis and treatment have reduced CMV morbidity and mortality, but at times promote development of antiviral-resistant CMV strains that can significantly contribute to adverse clinical outcomes in transplant recipients. We have investigated CMV genotypes in transplant recipients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
